Literature DB >> 9757636

[Concomitant cardiac and pulmonary operation, the profits of not using cardio-pulmonary bypass].

H Meguro1, R Kohiyama, S Murata, M Sato, H Adachi, T Ino, S Okada, K Futsuhara, M Miyata.   

Abstract

We performed off pump CABG (coronary artery bypass grafting) and right upper lobectomy with R2a lymph nodes dissection on the patient suffered from both lung cancer in the right S1 and stenotic lesion in the left anterior descending artery. Because the coronary lesion was long-segmented one, it was not suitable for percutaneous transluminal coronary angioplasty. To perform absolutely curative operation for the lung cancer, CABG was undergone simultaneously under off pump condition. It is generally feared that the cardiovascular surgery under CPB may have adverse effect for the patient with malignant lesion. Off pump CABG is expected to avoid such disadvantage of CPB, and thought to be suitable method for such a patient as we present above.

Entities:  

Mesh:

Year:  1998        PMID: 9757636

Source DB:  PubMed          Journal:  Kyobu Geka        ISSN: 0021-5252


  3 in total

1.  Minimally invasive surgery for lung cancer with coronary artery disease.

Authors:  K Hazama; A Akashi; N Hirata; A Amemiya; Y Maehata; Y Kosakai
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-04

Review 2.  Off-pump coronary artery bypass surgery in patients with coronary artery disease and malign neoplasia: results of ten patients and review of the literature.

Authors:  Ibrahim Ozsöyler; Levent Yilik; Sahin Bozok; Bilgin Emrecan; Mert Kestelli; Nagihan Karahan; Ali Gürbüz
Journal:  Heart Vessels       Date:  2006-11-27       Impact factor: 2.037

3.  Simultaneously performed off-pump coronary artery bypass grafting and colectomy: a case report.

Authors:  Panagiotis Dedeilias; Ioannis Nenekidis; Efstratios Koletsis; Nikolaos G Baikoussis; Panagiotis Hountis; Dimitrios Exarhos; Serafim Klimopoulos
Journal:  World J Surg Oncol       Date:  2010-06-15       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.